Related content

Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells

By                

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 151-160

Spandidos Publications

Access to resources Recommend Favorite

Genetic polymorphisms of interleukin-1 beta ( IL-1B ) and IL-1 receptor antagonist ( IL-1RN ) and breast cancer risk in Korean women

By Lee Kyoung-Mu   Park Sue   Hamajima Nobuyuki   Tajima Kazuo   Choi Ji-Yeob   Noh Dong-Young   Ahn Sei-Hyun   Yoo Keun-Young   Hirvonen Ari   Kang Daehee  

Breast Cancer Research and Treatment, Vol. 96, Iss. 2, 2006-03 ,pp. : 197-202

Springer Publishing Company

Access to resources Recommend Favorite

Onapristone, a Progesterone Receptor Antagonist, as First-line Therapy in Primary Breast Cancer

By Robertson J.F.R.   Willsher P.C.   Winterbottom L.   Blamey R.W.   Thorpe S.  

European Journal of Cancer, Vol. 35, Iss. 2, 1999-02 ,pp. : 214-218

Elsevier

Access to resources Recommend Favorite

Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer

By Linderholm Barbro  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 457-465

Springer Publishing Company

Access to resources Recommend Favorite

Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide

By Hesketh Paul   Younger Jerry   Sanz-Altamira Pedro   Hayden Melissa   Bushey Julie   Trainor Brian   Krentzin Michael   Nowd Peter   Arnaoutakis Konstantinos   Hesketh Ann  

Supportive Care in Cancer, Vol. 17, Iss. 8, 2009-08 ,pp. : 1065-1070

Springer Publishing Company

Access to resources Recommend Favorite